Nov 29, 2021 9:29 AM
BACK TO TOP
KSE100
37,167.02
-686.55
(-1.81%)
ALLSHR
28,001.30
-357.12
(-1.26%)
KSE30
17,273.97
-450.05
(-2.54%)
KMI30
61,443.48
-1695.59
(-2.69%)
BKTi
12,818.71
-316.11
(-2.41%)
OGTi
16,189.78
-439.79
(-2.64%)
KMIALLSHR
18,182.39
-327.85
(-1.77%)
NTIPGI
7,792.80
-150.30
(-1.89%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.762.17
9.68
(1.29%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Oct 29, 2021 12:08 PM
REG
FUT
ODL
Open
747.00
High
768.00
Low
747.00
Volume
22,800
CIRCUIT BREAKER
696.05 — 808.93
DAY RANGE
747.00 — 768.00
52-WEEK RANGE
561.00 — 819.00
Ask Price
762.17
Ask Volume
400
Bid Price
762.17
Bid Volume
0
LDCP
752.49
VAR
10.00
HAIRCUT
15.00
P/E Ratio (TTM) **
14.59
1-Year Change *
26.65%
YTD Change *
0.90%

No record found

Open
0.00
High
740.00
Low
740.00
Close
740.00
Change
-1.66%
LDCP
752.49
Volume
3
Total Trades
1
CIRCUIT BREAKER
677.24 — 827.74
DAY RANGE
740.00 — 740.00
Ask Price
770.70
Ask Volume
1
Bid Price
742.01
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Syed Anis AhmedCEO
Mr. Munir A. ShaikhChairman
Mr. Humayun AltafCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
74,616,673.18
Shares
97,900,302
Free Float
21,057,809
Free Float
21.51%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 27, 2021Transmission of Quarterly Report for the Period Ended June 30, 2021 View   PDF
Aug 27, 2021Financial Results for the Quarter Ended June 30, 2021 View   PDF
Apr 30, 2021Transmission of Quarterly Report for the Period Ended March 31, 2021 View   PDF
Apr 23, 2021Financial Results for the 1st Quarter Ended March 31, 2021 View   PDF
Mar 31, 2021Transmission of Annual Report for the Year Ended December 31st, 2020 View   PDF
Feb 26, 2021Financial Results for the Year Ended December 31,2020 View   PDF
Oct 29, 2020Transmission of Quarterly Report for the Period Ended September 30, 2020 View   PDF
Oct 28, 2020Financial Result for the Quarter Ended September 30th, 2020 View   PDF
Aug 28, 2020Transmission of Quarterly Report for the Period Ended June 30, 2020 View   PDF
Aug 28, 2020Financial Results for the Quarter Ended June 30th, 2020 View   PDF
DateTitleDocument
Aug 17, 2021Board Meeting View   PDF
Apr 22, 2021Certified Copy of Resolution passed at the 72nd Annual General Meeting View   PDF
Apr 16, 2021Board Meeting View   
Apr 6, 2021Board Meeting Other Than Financial Results View   PDF
Mar 29, 2021Notice of Annual General Meeting View   PDF
Feb 15, 2021Board Meeting View   PDF
Oct 20, 2020Board Meeting View   
Aug 20, 2020Board Meeting View   PDF
May 28, 2020Board Meeting in Progress View   
May 21, 2020Board Meeting View   
DateTitleDocument
Sep 23, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Sep 22, 2021Dispatch of Interim Cash Dividend View   PDF
Jun 4, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
May 4, 2021Credit of Final Cash Dividend View   
May 4, 2021Credit of Final Cash Dividend
REVOKED
View   
Mar 8, 2021Unusual Movement in price or volume of M/s Abbott Laboratories (Pakistan) Limited (ABOT) View   
Mar 8, 2021ABOT | Abbott Laboratories (Pakistan) Limited PDF
Dec 18, 2020Information under regulation No. 5.6.1(d) of PSX Rule Book View   PDF
Dec 15, 2020Corporate Briefing Session View   PDF
Sep 18, 2020Dispatch of Interim Cash Dividend View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales35,283,37730,155,87529,719,27926,088,233
Profit after Taxation4,535,2491,299,8852,694,3334,205,232
EPS46.3313.2827.5242.95
Q2 2021Q1 2021Q3 2020Q2 2020
Sales10,907,1919,890,7928,438,2418,472,178
Profit after Taxation1,839,4971,442,492985,4441,257,547
EPS18.7914.7310.0712.85
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)34.6428.2832.8938.67
Net Profit Margin (%)12.854.319.0716.12
EPS Growth (%)248.87(51.74)(35.93)4.55
PEG0.07(0.66)(0.64)3.57

Payouts

DateFinancial ResultsDetailsBook Closure
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016
August 17, 2015 1:36 PM30/06/2015(HYR) 100% (D) 04/09/2015 - 11/09/2015
February 24, 2015 1:46 PM31/12/2014(YR) 48% (D) 16/04/2014 - 23/04/2014
August 21, 2014 2:16 PM30/06/2014(HYR) 30%(I) (D) 08/09/2014 - 15/09/2014
February 13, 2014 2:24 PM31/12/2013(YR) 40% (D) 09/04/2014 - 16/04/2014

Financial Reports